ClinicalTrials.govpublic full text
A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer
breast cancer, metastasis, recurrent, locally-advanced, or 'triple negative' metastatic breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879817
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.